Peter Daly
Keine laufenden Positionen mehr
Profil
Peter Daly is Chief Executive Officer of NeuroCure Ltd.
He is a Co-Founder of EiRx Therapeutics and served as Chief Executive Officer from 1998 to 2002.
Previously, he was Manager of Cahill May Roberts Group Plc.
Ehemalige bekannte Positionen von Peter Daly
| Unternehmen | Position | Ende |
|---|---|---|
EiRx Therapeutics Plc
 EiRx Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services The Group's principal activity is discovering and developing novel therapeutics for the treatment of cancer. It focuses on the study of cancer cell survival and growth, with a research base encompassing apoptosis biology, cancer biomarkers and the metabolic basis of drug resistance in tumours. The Group creates intellectual property that seeks to exploit through in-house product development and licensing. | Präsident | 01.01.2002 |
Cahill May Roberts Ltd.
 Cahill May Roberts Ltd. Medical DistributorsDistribution Services Part of UniPhar Group Ltd., Cahill May Roberts Ltd. is a pharmaceutical product distributor. The company is based in Chapelizod, Ireland. Cahill May Roberts was acquired by UniPhar Group Ltd. from McKesson Europe AG on April 30, 2013 for $63.43 million. | Corporate Officer/Principal | - |
NeuroCure Ltd.
 NeuroCure Ltd. BiotechnologyHealth Technology NeuroCure Ltd. manufactures drugs to cure psychiatric and central nervous system diseases. It has programs available for out-licensing and its licensing novel use inventions supported by clinical data and with novel formulations. The company was founded by Ted Dinan and Peter Daly in 2003 and is headquartered in Dublin, Ireland. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
EiRx Therapeutics Plc
EiRx Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services The Group's principal activity is discovering and developing novel therapeutics for the treatment of cancer. It focuses on the study of cancer cell survival and growth, with a research base encompassing apoptosis biology, cancer biomarkers and the metabolic basis of drug resistance in tumours. The Group creates intellectual property that seeks to exploit through in-house product development and licensing. | Commercial Services |
Cahill May Roberts Ltd.
Cahill May Roberts Ltd. Medical DistributorsDistribution Services Part of UniPhar Group Ltd., Cahill May Roberts Ltd. is a pharmaceutical product distributor. The company is based in Chapelizod, Ireland. Cahill May Roberts was acquired by UniPhar Group Ltd. from McKesson Europe AG on April 30, 2013 for $63.43 million. | Distribution Services |
NeuroCure Ltd.
NeuroCure Ltd. BiotechnologyHealth Technology NeuroCure Ltd. manufactures drugs to cure psychiatric and central nervous system diseases. It has programs available for out-licensing and its licensing novel use inventions supported by clinical data and with novel formulations. The company was founded by Ted Dinan and Peter Daly in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
